LouisianaLouisiana task force studies access and costs for GLP-1 medicines
Louisiana's PACE Task Force studies GLP-1 medicines used for diabetes and weight management, reports its findings, and recommends possible legislation.
What it does
The PACE Task Force studies access to GLP-1 medicines and their insurance costs. Its findings are due to legislative insurance committees by February 12, 2027, when the group must end unless it finishes earlier.
Argument forStudying prices, coverage barriers, and insurance costs could help lawmakers weigh ways to make these medicines more accessible.
Argument againstPatients have no designated seat, so the group's recommendations could give less weight to their experiences getting treatment.
More detail
The PACE Task Force studies GLP-1 medicines and recommends possible legislation. The five seats cover state insurance, health, and pharmacy officials, a health-plan association representative, and a licensed healthcare provider specializing in hormone disorders and obesity. The Louisiana Department of Insurance provides staff. Members serve without pay, except daily allowances or expense payments available through their own organizations. The legislature recommends study topics, including medicine prices, coverage barriers, and insurance costs. Designee names were due August 1, 2026, and the first meeting was required by September 1, 2026. The group must submit its report and end by February 12, 2027; it ends earlier if its work concludes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 5Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.Latest
- Jun 1Received in the Senate; read by title. Rules suspended. Read second time by title and concurred in by a vote of 33 yeas and 0 nays. Ordered returned to the House.Passed 2nd Chamber
- Vote recorded CONCUR (#1622). Result: pass.Upper
- Jun 1Received from the Senate without amendments.Minor
- Jun 1Enrolled and signed by the Speaker of the House.Minor
- Jun 1Signed by the President of the Senate.
- May 31Rules suspended, called out of its regular order.
- Vote recorded FINAL CONSIDERATION (#1809). Result: pass.Lower
- May 31Read by title, roll called on final consideration, yeas 81, nays 11. The resolution was adopted and ordered to the Senate.Passed 1st Chamber
- May 29Scheduled for floor debate on 05/31/2026.
- May 28Read by title, rules suspended, passed to 3rd reading.Minor
- May 27Read by title. Lies over under the rules.Introduced
Healthcare